Medical Care
Global Sex Hormone Antagonist Market Research Report 2025
- Mar 11, 25
- ID: 78174
- Pages: 81
- Figures: 88
- Views: 11
The global market for Sex Hormone Antagonist was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Sex Hormone Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sex Hormone Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Sex Hormone Antagonist in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Sex Hormone Antagonist include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Eli Lilly and Company, Kyowa Kirin International, Bayer, Orion Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sex Hormone Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sex Hormone Antagonist.
The Sex Hormone Antagonist market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sex Hormone Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sex Hormone Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Eli Lilly and Company
Kyowa Kirin International
Bayer
Orion Corporation
Hengrui
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Segment by Type
Antiestrogen
Antiprogestin
Antiandrogen
Segment by Application
Breast Cancer
Prostate Cancer
Endometriosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sex Hormone Antagonist company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Sex Hormone Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sex Hormone Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Sex Hormone Antagonist in Breast Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Sex Hormone Antagonist include Pfizer, Johnson & Johnson, AstraZeneca, Astellas, Merck, Sanofi, Eli Lilly and Company, Kyowa Kirin International, Bayer, Orion Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sex Hormone Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sex Hormone Antagonist.
The Sex Hormone Antagonist market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sex Hormone Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sex Hormone Antagonist companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Eli Lilly and Company
Kyowa Kirin International
Bayer
Orion Corporation
Hengrui
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Segment by Type
Antiestrogen
Antiprogestin
Antiandrogen
Segment by Application
Breast Cancer
Prostate Cancer
Endometriosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sex Hormone Antagonist company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sex Hormone Antagonist Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antiestrogen
1.2.3 Antiprogestin
1.2.4 Antiandrogen
1.3 Market by Application
1.3.1 Global Sex Hormone Antagonist Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Endometriosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sex Hormone Antagonist Market Perspective (2020-2031)
2.2 Global Sex Hormone Antagonist Growth Trends by Region
2.2.1 Global Sex Hormone Antagonist Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sex Hormone Antagonist Historic Market Size by Region (2020-2025)
2.2.3 Sex Hormone Antagonist Forecasted Market Size by Region (2026-2031)
2.3 Sex Hormone Antagonist Market Dynamics
2.3.1 Sex Hormone Antagonist Industry Trends
2.3.2 Sex Hormone Antagonist Market Drivers
2.3.3 Sex Hormone Antagonist Market Challenges
2.3.4 Sex Hormone Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sex Hormone Antagonist Players by Revenue
3.1.1 Global Top Sex Hormone Antagonist Players by Revenue (2020-2025)
3.1.2 Global Sex Hormone Antagonist Revenue Market Share by Players (2020-2025)
3.2 Global Sex Hormone Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sex Hormone Antagonist Revenue
3.4 Global Sex Hormone Antagonist Market Concentration Ratio
3.4.1 Global Sex Hormone Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sex Hormone Antagonist Revenue in 2024
3.5 Global Key Players of Sex Hormone Antagonist Head office and Area Served
3.6 Global Key Players of Sex Hormone Antagonist, Product and Application
3.7 Global Key Players of Sex Hormone Antagonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sex Hormone Antagonist Breakdown Data by Type
4.1 Global Sex Hormone Antagonist Historic Market Size by Type (2020-2025)
4.2 Global Sex Hormone Antagonist Forecasted Market Size by Type (2026-2031)
5 Sex Hormone Antagonist Breakdown Data by Application
5.1 Global Sex Hormone Antagonist Historic Market Size by Application (2020-2025)
5.2 Global Sex Hormone Antagonist Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sex Hormone Antagonist Market Size (2020-2031)
6.2 North America Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sex Hormone Antagonist Market Size by Country (2020-2025)
6.4 North America Sex Hormone Antagonist Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sex Hormone Antagonist Market Size (2020-2031)
7.2 Europe Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sex Hormone Antagonist Market Size by Country (2020-2025)
7.4 Europe Sex Hormone Antagonist Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sex Hormone Antagonist Market Size (2020-2031)
8.2 Asia-Pacific Sex Hormone Antagonist Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sex Hormone Antagonist Market Size by Region (2020-2025)
8.4 Asia-Pacific Sex Hormone Antagonist Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sex Hormone Antagonist Market Size (2020-2031)
9.2 Latin America Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sex Hormone Antagonist Market Size by Country (2020-2025)
9.4 Latin America Sex Hormone Antagonist Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sex Hormone Antagonist Market Size (2020-2031)
10.2 Middle East & Africa Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sex Hormone Antagonist Market Size by Country (2020-2025)
10.4 Middle East & Africa Sex Hormone Antagonist Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sex Hormone Antagonist Introduction
11.1.4 Pfizer Revenue in Sex Hormone Antagonist Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Sex Hormone Antagonist Introduction
11.2.4 Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Sex Hormone Antagonist Introduction
11.3.4 AstraZeneca Revenue in Sex Hormone Antagonist Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Astellas
11.4.1 Astellas Company Details
11.4.2 Astellas Business Overview
11.4.3 Astellas Sex Hormone Antagonist Introduction
11.4.4 Astellas Revenue in Sex Hormone Antagonist Business (2020-2025)
11.4.5 Astellas Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Sex Hormone Antagonist Introduction
11.5.4 Merck Revenue in Sex Hormone Antagonist Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Sex Hormone Antagonist Introduction
11.6.4 Sanofi Revenue in Sex Hormone Antagonist Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Sex Hormone Antagonist Introduction
11.7.4 Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2020-2025)
11.7.5 Eli Lilly and Company Recent Development
11.8 Kyowa Kirin International
11.8.1 Kyowa Kirin International Company Details
11.8.2 Kyowa Kirin International Business Overview
11.8.3 Kyowa Kirin International Sex Hormone Antagonist Introduction
11.8.4 Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2020-2025)
11.8.5 Kyowa Kirin International Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Sex Hormone Antagonist Introduction
11.9.4 Bayer Revenue in Sex Hormone Antagonist Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Sex Hormone Antagonist Introduction
11.10.4 Orion Corporation Revenue in Sex Hormone Antagonist Business (2020-2025)
11.10.5 Orion Corporation Recent Development
11.11 Hengrui
11.11.1 Hengrui Company Details
11.11.2 Hengrui Business Overview
11.11.3 Hengrui Sex Hormone Antagonist Introduction
11.11.4 Hengrui Revenue in Sex Hormone Antagonist Business (2020-2025)
11.11.5 Hengrui Recent Development
11.12 Schering-Plough
11.12.1 Schering-Plough Company Details
11.12.2 Schering-Plough Business Overview
11.12.3 Schering-Plough Sex Hormone Antagonist Introduction
11.12.4 Schering-Plough Revenue in Sex Hormone Antagonist Business (2020-2025)
11.12.5 Schering-Plough Recent Development
11.13 Hinova Pharma
11.13.1 Hinova Pharma Company Details
11.13.2 Hinova Pharma Business Overview
11.13.3 Hinova Pharma Sex Hormone Antagonist Introduction
11.13.4 Hinova Pharma Revenue in Sex Hormone Antagonist Business (2020-2025)
11.13.5 Hinova Pharma Recent Development
11.14 Jiangsu Hengrui Pharmaceuticals
11.14.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.14.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.14.3 Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Introduction
11.14.4 Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2020-2025)
11.14.5 Jiangsu Hengrui Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sex Hormone Antagonist Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antiestrogen
1.2.3 Antiprogestin
1.2.4 Antiandrogen
1.3 Market by Application
1.3.1 Global Sex Hormone Antagonist Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Endometriosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sex Hormone Antagonist Market Perspective (2020-2031)
2.2 Global Sex Hormone Antagonist Growth Trends by Region
2.2.1 Global Sex Hormone Antagonist Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sex Hormone Antagonist Historic Market Size by Region (2020-2025)
2.2.3 Sex Hormone Antagonist Forecasted Market Size by Region (2026-2031)
2.3 Sex Hormone Antagonist Market Dynamics
2.3.1 Sex Hormone Antagonist Industry Trends
2.3.2 Sex Hormone Antagonist Market Drivers
2.3.3 Sex Hormone Antagonist Market Challenges
2.3.4 Sex Hormone Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sex Hormone Antagonist Players by Revenue
3.1.1 Global Top Sex Hormone Antagonist Players by Revenue (2020-2025)
3.1.2 Global Sex Hormone Antagonist Revenue Market Share by Players (2020-2025)
3.2 Global Sex Hormone Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sex Hormone Antagonist Revenue
3.4 Global Sex Hormone Antagonist Market Concentration Ratio
3.4.1 Global Sex Hormone Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sex Hormone Antagonist Revenue in 2024
3.5 Global Key Players of Sex Hormone Antagonist Head office and Area Served
3.6 Global Key Players of Sex Hormone Antagonist, Product and Application
3.7 Global Key Players of Sex Hormone Antagonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sex Hormone Antagonist Breakdown Data by Type
4.1 Global Sex Hormone Antagonist Historic Market Size by Type (2020-2025)
4.2 Global Sex Hormone Antagonist Forecasted Market Size by Type (2026-2031)
5 Sex Hormone Antagonist Breakdown Data by Application
5.1 Global Sex Hormone Antagonist Historic Market Size by Application (2020-2025)
5.2 Global Sex Hormone Antagonist Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sex Hormone Antagonist Market Size (2020-2031)
6.2 North America Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sex Hormone Antagonist Market Size by Country (2020-2025)
6.4 North America Sex Hormone Antagonist Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sex Hormone Antagonist Market Size (2020-2031)
7.2 Europe Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sex Hormone Antagonist Market Size by Country (2020-2025)
7.4 Europe Sex Hormone Antagonist Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sex Hormone Antagonist Market Size (2020-2031)
8.2 Asia-Pacific Sex Hormone Antagonist Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sex Hormone Antagonist Market Size by Region (2020-2025)
8.4 Asia-Pacific Sex Hormone Antagonist Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sex Hormone Antagonist Market Size (2020-2031)
9.2 Latin America Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sex Hormone Antagonist Market Size by Country (2020-2025)
9.4 Latin America Sex Hormone Antagonist Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sex Hormone Antagonist Market Size (2020-2031)
10.2 Middle East & Africa Sex Hormone Antagonist Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sex Hormone Antagonist Market Size by Country (2020-2025)
10.4 Middle East & Africa Sex Hormone Antagonist Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sex Hormone Antagonist Introduction
11.1.4 Pfizer Revenue in Sex Hormone Antagonist Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Sex Hormone Antagonist Introduction
11.2.4 Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Sex Hormone Antagonist Introduction
11.3.4 AstraZeneca Revenue in Sex Hormone Antagonist Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Astellas
11.4.1 Astellas Company Details
11.4.2 Astellas Business Overview
11.4.3 Astellas Sex Hormone Antagonist Introduction
11.4.4 Astellas Revenue in Sex Hormone Antagonist Business (2020-2025)
11.4.5 Astellas Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Sex Hormone Antagonist Introduction
11.5.4 Merck Revenue in Sex Hormone Antagonist Business (2020-2025)
11.5.5 Merck Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Sex Hormone Antagonist Introduction
11.6.4 Sanofi Revenue in Sex Hormone Antagonist Business (2020-2025)
11.6.5 Sanofi Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Sex Hormone Antagonist Introduction
11.7.4 Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2020-2025)
11.7.5 Eli Lilly and Company Recent Development
11.8 Kyowa Kirin International
11.8.1 Kyowa Kirin International Company Details
11.8.2 Kyowa Kirin International Business Overview
11.8.3 Kyowa Kirin International Sex Hormone Antagonist Introduction
11.8.4 Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2020-2025)
11.8.5 Kyowa Kirin International Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Sex Hormone Antagonist Introduction
11.9.4 Bayer Revenue in Sex Hormone Antagonist Business (2020-2025)
11.9.5 Bayer Recent Development
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Sex Hormone Antagonist Introduction
11.10.4 Orion Corporation Revenue in Sex Hormone Antagonist Business (2020-2025)
11.10.5 Orion Corporation Recent Development
11.11 Hengrui
11.11.1 Hengrui Company Details
11.11.2 Hengrui Business Overview
11.11.3 Hengrui Sex Hormone Antagonist Introduction
11.11.4 Hengrui Revenue in Sex Hormone Antagonist Business (2020-2025)
11.11.5 Hengrui Recent Development
11.12 Schering-Plough
11.12.1 Schering-Plough Company Details
11.12.2 Schering-Plough Business Overview
11.12.3 Schering-Plough Sex Hormone Antagonist Introduction
11.12.4 Schering-Plough Revenue in Sex Hormone Antagonist Business (2020-2025)
11.12.5 Schering-Plough Recent Development
11.13 Hinova Pharma
11.13.1 Hinova Pharma Company Details
11.13.2 Hinova Pharma Business Overview
11.13.3 Hinova Pharma Sex Hormone Antagonist Introduction
11.13.4 Hinova Pharma Revenue in Sex Hormone Antagonist Business (2020-2025)
11.13.5 Hinova Pharma Recent Development
11.14 Jiangsu Hengrui Pharmaceuticals
11.14.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.14.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.14.3 Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Introduction
11.14.4 Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2020-2025)
11.14.5 Jiangsu Hengrui Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sex Hormone Antagonist Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antiestrogen
Table 3. Key Players of Antiprogestin
Table 4. Key Players of Antiandrogen
Table 5. Global Sex Hormone Antagonist Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sex Hormone Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sex Hormone Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sex Hormone Antagonist Market Share by Region (2020-2025)
Table 9. Global Sex Hormone Antagonist Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sex Hormone Antagonist Market Share by Region (2026-2031)
Table 11. Sex Hormone Antagonist Market Trends
Table 12. Sex Hormone Antagonist Market Drivers
Table 13. Sex Hormone Antagonist Market Challenges
Table 14. Sex Hormone Antagonist Market Restraints
Table 15. Global Sex Hormone Antagonist Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sex Hormone Antagonist Market Share by Players (2020-2025)
Table 17. Global Top Sex Hormone Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2024)
Table 18. Ranking of Global Top Sex Hormone Antagonist Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sex Hormone Antagonist Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sex Hormone Antagonist, Headquarters and Area Served
Table 21. Global Key Players of Sex Hormone Antagonist, Product and Application
Table 22. Global Key Players of Sex Hormone Antagonist, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sex Hormone Antagonist Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sex Hormone Antagonist Revenue Market Share by Type (2020-2025)
Table 26. Global Sex Hormone Antagonist Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sex Hormone Antagonist Revenue Market Share by Type (2026-2031)
Table 28. Global Sex Hormone Antagonist Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sex Hormone Antagonist Revenue Market Share by Application (2020-2025)
Table 30. Global Sex Hormone Antagonist Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sex Hormone Antagonist Revenue Market Share by Application (2026-2031)
Table 32. North America Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sex Hormone Antagonist Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sex Hormone Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sex Hormone Antagonist Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Sex Hormone Antagonist Product
Table 50. Pfizer Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Sex Hormone Antagonist Product
Table 55. Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. AstraZeneca Company Details
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Sex Hormone Antagonist Product
Table 60. AstraZeneca Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Astellas Company Details
Table 63. Astellas Business Overview
Table 64. Astellas Sex Hormone Antagonist Product
Table 65. Astellas Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 66. Astellas Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Sex Hormone Antagonist Product
Table 70. Merck Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Sex Hormone Antagonist Product
Table 75. Sanofi Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Eli Lilly and Company Company Details
Table 78. Eli Lilly and Company Business Overview
Table 79. Eli Lilly and Company Sex Hormone Antagonist Product
Table 80. Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 81. Eli Lilly and Company Recent Development
Table 82. Kyowa Kirin International Company Details
Table 83. Kyowa Kirin International Business Overview
Table 84. Kyowa Kirin International Sex Hormone Antagonist Product
Table 85. Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 86. Kyowa Kirin International Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Sex Hormone Antagonist Product
Table 90. Bayer Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Orion Corporation Company Details
Table 93. Orion Corporation Business Overview
Table 94. Orion Corporation Sex Hormone Antagonist Product
Table 95. Orion Corporation Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 96. Orion Corporation Recent Development
Table 97. Hengrui Company Details
Table 98. Hengrui Business Overview
Table 99. Hengrui Sex Hormone Antagonist Product
Table 100. Hengrui Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 101. Hengrui Recent Development
Table 102. Schering-Plough Company Details
Table 103. Schering-Plough Business Overview
Table 104. Schering-Plough Sex Hormone Antagonist Product
Table 105. Schering-Plough Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 106. Schering-Plough Recent Development
Table 107. Hinova Pharma Company Details
Table 108. Hinova Pharma Business Overview
Table 109. Hinova Pharma Sex Hormone Antagonist Product
Table 110. Hinova Pharma Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 111. Hinova Pharma Recent Development
Table 112. Jiangsu Hengrui Pharmaceuticals Company Details
Table 113. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 114. Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Product
Table 115. Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 116. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Sex Hormone Antagonist Picture
Figure 2. Global Sex Hormone Antagonist Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sex Hormone Antagonist Market Share by Type: 2024 VS 2031
Figure 4. Antiestrogen Features
Figure 5. Antiprogestin Features
Figure 6. Antiandrogen Features
Figure 7. Global Sex Hormone Antagonist Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sex Hormone Antagonist Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Endometriosis Case Studies
Figure 12. Others Case Studies
Figure 13. Sex Hormone Antagonist Report Years Considered
Figure 14. Global Sex Hormone Antagonist Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sex Hormone Antagonist Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sex Hormone Antagonist Market Share by Region: 2024 VS 2031
Figure 17. Global Sex Hormone Antagonist Market Share by Players in 2024
Figure 18. Global Top Sex Hormone Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Sex Hormone Antagonist Revenue in 2024
Figure 20. North America Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 22. United States Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 26. Germany Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sex Hormone Antagonist Market Share by Region (2020-2031)
Figure 34. China Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 42. Mexico Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 46. Turkey Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 51. AstraZeneca Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 52. Astellas Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 56. Kyowa Kirin International Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 57. Bayer Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 58. Orion Corporation Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 59. Hengrui Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 60. Schering-Plough Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 61. Hinova Pharma Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 62. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Sex Hormone Antagonist Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antiestrogen
Table 3. Key Players of Antiprogestin
Table 4. Key Players of Antiandrogen
Table 5. Global Sex Hormone Antagonist Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sex Hormone Antagonist Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sex Hormone Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sex Hormone Antagonist Market Share by Region (2020-2025)
Table 9. Global Sex Hormone Antagonist Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sex Hormone Antagonist Market Share by Region (2026-2031)
Table 11. Sex Hormone Antagonist Market Trends
Table 12. Sex Hormone Antagonist Market Drivers
Table 13. Sex Hormone Antagonist Market Challenges
Table 14. Sex Hormone Antagonist Market Restraints
Table 15. Global Sex Hormone Antagonist Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sex Hormone Antagonist Market Share by Players (2020-2025)
Table 17. Global Top Sex Hormone Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2024)
Table 18. Ranking of Global Top Sex Hormone Antagonist Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sex Hormone Antagonist Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sex Hormone Antagonist, Headquarters and Area Served
Table 21. Global Key Players of Sex Hormone Antagonist, Product and Application
Table 22. Global Key Players of Sex Hormone Antagonist, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sex Hormone Antagonist Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sex Hormone Antagonist Revenue Market Share by Type (2020-2025)
Table 26. Global Sex Hormone Antagonist Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sex Hormone Antagonist Revenue Market Share by Type (2026-2031)
Table 28. Global Sex Hormone Antagonist Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sex Hormone Antagonist Revenue Market Share by Application (2020-2025)
Table 30. Global Sex Hormone Antagonist Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sex Hormone Antagonist Revenue Market Share by Application (2026-2031)
Table 32. North America Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sex Hormone Antagonist Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sex Hormone Antagonist Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sex Hormone Antagonist Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sex Hormone Antagonist Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sex Hormone Antagonist Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sex Hormone Antagonist Market Size by Country (2026-2031) & (US$ Million)
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Sex Hormone Antagonist Product
Table 50. Pfizer Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Sex Hormone Antagonist Product
Table 55. Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. AstraZeneca Company Details
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Sex Hormone Antagonist Product
Table 60. AstraZeneca Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Astellas Company Details
Table 63. Astellas Business Overview
Table 64. Astellas Sex Hormone Antagonist Product
Table 65. Astellas Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 66. Astellas Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Sex Hormone Antagonist Product
Table 70. Merck Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Sanofi Company Details
Table 73. Sanofi Business Overview
Table 74. Sanofi Sex Hormone Antagonist Product
Table 75. Sanofi Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Eli Lilly and Company Company Details
Table 78. Eli Lilly and Company Business Overview
Table 79. Eli Lilly and Company Sex Hormone Antagonist Product
Table 80. Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 81. Eli Lilly and Company Recent Development
Table 82. Kyowa Kirin International Company Details
Table 83. Kyowa Kirin International Business Overview
Table 84. Kyowa Kirin International Sex Hormone Antagonist Product
Table 85. Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 86. Kyowa Kirin International Recent Development
Table 87. Bayer Company Details
Table 88. Bayer Business Overview
Table 89. Bayer Sex Hormone Antagonist Product
Table 90. Bayer Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 91. Bayer Recent Development
Table 92. Orion Corporation Company Details
Table 93. Orion Corporation Business Overview
Table 94. Orion Corporation Sex Hormone Antagonist Product
Table 95. Orion Corporation Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 96. Orion Corporation Recent Development
Table 97. Hengrui Company Details
Table 98. Hengrui Business Overview
Table 99. Hengrui Sex Hormone Antagonist Product
Table 100. Hengrui Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 101. Hengrui Recent Development
Table 102. Schering-Plough Company Details
Table 103. Schering-Plough Business Overview
Table 104. Schering-Plough Sex Hormone Antagonist Product
Table 105. Schering-Plough Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 106. Schering-Plough Recent Development
Table 107. Hinova Pharma Company Details
Table 108. Hinova Pharma Business Overview
Table 109. Hinova Pharma Sex Hormone Antagonist Product
Table 110. Hinova Pharma Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 111. Hinova Pharma Recent Development
Table 112. Jiangsu Hengrui Pharmaceuticals Company Details
Table 113. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 114. Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Product
Table 115. Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2020-2025) & (US$ Million)
Table 116. Jiangsu Hengrui Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Sex Hormone Antagonist Picture
Figure 2. Global Sex Hormone Antagonist Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sex Hormone Antagonist Market Share by Type: 2024 VS 2031
Figure 4. Antiestrogen Features
Figure 5. Antiprogestin Features
Figure 6. Antiandrogen Features
Figure 7. Global Sex Hormone Antagonist Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sex Hormone Antagonist Market Share by Application: 2024 VS 2031
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Endometriosis Case Studies
Figure 12. Others Case Studies
Figure 13. Sex Hormone Antagonist Report Years Considered
Figure 14. Global Sex Hormone Antagonist Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sex Hormone Antagonist Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sex Hormone Antagonist Market Share by Region: 2024 VS 2031
Figure 17. Global Sex Hormone Antagonist Market Share by Players in 2024
Figure 18. Global Top Sex Hormone Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Sex Hormone Antagonist Revenue in 2024
Figure 20. North America Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 22. United States Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 26. Germany Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sex Hormone Antagonist Market Share by Region (2020-2031)
Figure 34. China Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 42. Mexico Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sex Hormone Antagonist Market Share by Country (2020-2031)
Figure 46. Turkey Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sex Hormone Antagonist Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Pfizer Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 50. Johnson & Johnson Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 51. AstraZeneca Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 52. Astellas Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 54. Sanofi Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 55. Eli Lilly and Company Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 56. Kyowa Kirin International Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 57. Bayer Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 58. Orion Corporation Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 59. Hengrui Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 60. Schering-Plough Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 61. Hinova Pharma Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 62. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Sex Hormone Antagonist Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232